Physician

Charles Mccanna, M.D.

According to 2025 Medicare claims, Charles Mccanna, M.D. (NPI: 1295141893) practices ophthalmology in the Milwaukee-Waukesha, WI market, with the plurality of this provider's patient population coming from Milwaukee, WI. This provider's primary affiliated billing organization is OPHTHALMOLOGY ASSOCIATES S C (NPI: 1063557890; TIN: 391484998) and primary practice location at 53110-3028.

Mccanna's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 918 traditional Medicare patients, billed 23,656 HCPCS/CPT codes, and received $1,384,567 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,440 prescription claims across 420 beneficiaries totaling $183,215 in drug costs, led by Restasis (Cyclosporine). DME data shows 99 claims. Open Payments data shows 22 records totaling $441. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $44,813 to $1,384,567. Similarly, Part D prescription costs have risen steadily, from $3,337 to $183,215. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	360	565	$44,813
2019	822	2,301	$200,491
2020	1,179	3,281	$248,520
2021	1,159	3,691	$457,570
2022	958	4,213	$639,417
2023	953	11,107	$1,132,751
2024	918	23,656	$1,384,567

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	15	46	$3,337
2016	74	390	$31,539
2017	105	464	$39,437
2018	124	579	$49,159
2019	203	496	$64,445
2020	288	875	$158,102
2021	360	1,295	$259,644
2022	420	1,564	$230,689
2023	409	1,551	$213,357
2024	420	1,440	$183,215

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	52	63	$3,500
2020	46	50	$2,843
2021	97	112	$6,344
2022	104	111	$7,038
2023	118	129	$9,207
2024	77	99	$7,765

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	122	685	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	232	251	$83
92014	Established patient complete exam of visual system	585	630	$80
92134	Imaging of retina	323	930	$29
92133	Imaging of optic nerve	95	110	$23

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	43	3,330	$63,428
Cyclosporine	Cyclosporine	23	1,515	$20,786
Simbrinza	Brinzolamide/Brimonidine Tart	57	3,336	$15,919
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	36	2,305	$10,586
Prednisolone Acetate	Prednisolone Acetate	211	9,195	$8,401

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2020	Frames, purchases	N	39	47	$3,126
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	20	21	$2,406
V2203	Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	N	N/R	12	$1,140
V2103	Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	N	18	19	$1,094

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$441	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles Mccanna, M.D.?

Tedicare shows public-source Medicare data for Charles Mccanna, M.D. (NPI 1295141893), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles Mccanna, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles Mccanna, M.D.?

Charles Mccanna, M.D. is linked to OPHTHALMOLOGY ASSOCIATES S C (billing NPI 1063557890) in the available physician profile data.

Does Charles Mccanna, M.D. have Open Payments data?

Charles Mccanna, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.